Literature DB >> 17603493

Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer.

Srinivas Nagaraj1, Kapil Gupta, Vladimir Pisarev, Leo Kinarsky, Simon Sherman, Loveleen Kang, Donna L Herber, Jonathan Schneck, Dmitry I Gabrilovich.   

Abstract

Antigen-specific CD8+ T-cell tolerance, induced by myeloid-derived suppressor cells (MDSCs), is one of the main mechanisms of tumor escape. Using in vivo models, we show here that MDSCs directly disrupt the binding of specific peptide-major histocompatibility complex (pMHC) dimers to CD8-expressing T cells through nitration of tyrosines in a T-cell receptor (TCR)-CD8 complex. This process makes CD8-expressing T cells unable to bind pMHC and to respond to the specific peptide, although they retain their ability to respond to nonspecific stimulation. Nitration of TCR-CD8 is induced by MDSCs through hyperproduction of reactive oxygen species and peroxynitrite during direct cell-cell contact. Molecular modeling suggests specific sites of nitration that might affect the conformational flexibility of TCR-CD8 and its interaction with pMHC. These data identify a previously unknown mechanism of T-cell tolerance in cancer that is also pertinent to many pathological conditions associated with accumulation of MDSCs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17603493      PMCID: PMC2135607          DOI: 10.1038/nm1609

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  42 in total

Review 1.  Tumor-induced immune dysfunctions caused by myeloid suppressor cells.

Authors:  V Bronte; P Serafini; E Apolloni; P Zanovello
Journal:  J Immunother       Date:  2001 Nov-Dec       Impact factor: 4.456

Review 2.  Role of immature myeloid cells in mechanisms of immune evasion in cancer.

Authors:  Sergei Kusmartsev; Dmitry I Gabrilovich
Journal:  Cancer Immunol Immunother       Date:  2005-07-27       Impact factor: 6.968

3.  A schistosome-expressed immunomodulatory glycoconjugate expands peritoneal Gr1(+) macrophages that suppress naive CD4(+) T cell proliferation via an IFN-gamma and nitric oxide-dependent mechanism.

Authors:  O Atochina; T Daly-Engel; D Piskorska; E McGuire; D A Harn
Journal:  J Immunol       Date:  2001-10-15       Impact factor: 5.422

Review 4.  Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression.

Authors:  Paolo Serafini; Ivan Borrello; Vincenzo Bronte
Journal:  Semin Cancer Biol       Date:  2005-09-15       Impact factor: 15.707

5.  Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host.

Authors:  Bo Huang; Ping-Ying Pan; Qingsheng Li; Alice I Sato; David E Levy; Jonathan Bromberg; Celia M Divino; Shu-Hsia Chen
Journal:  Cancer Res       Date:  2006-01-15       Impact factor: 12.701

6.  CD11b+/Gr-1+ myeloid suppressor cells cause T cell dysfunction after traumatic stress.

Authors:  Valeriya P Makarenkova; Vishal Bansal; Benjamin M Matta; Lori Ann Perez; Juan B Ochoa
Journal:  J Immunol       Date:  2006-02-15       Impact factor: 5.422

7.  CD34+ immune suppressive cells in the peripheral blood of patients with head and neck cancer.

Authors:  R Pandit; D M Lathers; N M Beal; T Garrity; M R Young
Journal:  Ann Otol Rhinol Laryngol       Date:  2000-08       Impact factor: 1.547

8.  Crystal structure of nitrated human manganese superoxide dismutase: mechanism of inactivation.

Authors:  Patrick Quint; Robbie Reutzel; Rose Mikulski; Robert McKenna; David N Silverman
Journal:  Free Radic Biol Med       Date:  2005-11-09       Impact factor: 7.376

Review 9.  Tumor immunity: a balancing act between T cell activation, macrophage activation and tumor-induced immune suppression.

Authors:  Pratima Sinha; Virginia K Clements; Seth Miller; Suzanne Ostrand-Rosenberg
Journal:  Cancer Immunol Immunother       Date:  2005-05-05       Impact factor: 6.968

10.  All-trans-retinoic acid eliminates immature myeloid cells from tumor-bearing mice and improves the effect of vaccination.

Authors:  Sergei Kusmartsev; Fengdong Cheng; Bin Yu; Yulia Nefedova; Eduardo Sotomayor; Richard Lush; Dmitry Gabrilovich
Journal:  Cancer Res       Date:  2003-08-01       Impact factor: 12.701

View more
  448 in total

1.  The role of Gr1+ cells after anti-CD20 treatment in type 1 diabetes in nonobese diabetic mice.

Authors:  Changyun Hu; Wei Du; Xiaojun Zhang; F Susan Wong; Li Wen
Journal:  J Immunol       Date:  2011-12-02       Impact factor: 5.422

2.  Targeted imaging of tumor-associated M2 macrophages using a macromolecular contrast agent PG-Gd-NIR813.

Authors:  Marites P Melancon; Wei Lu; Qian Huang; Prakash Thapa; Dapeng Zhou; Chaan Ng; Chun Li
Journal:  Biomaterials       Date:  2010-09       Impact factor: 12.479

3.  Adoptive T cell therapy promotes the emergence of genomically altered tumor escape variants.

Authors:  Karen M Kaluza; Jill M Thompson; Timothy J Kottke; Heather C Flynn Gilmer; Darlene L Knutson; Richard G Vile
Journal:  Int J Cancer       Date:  2011-11-30       Impact factor: 7.396

Review 4.  Myeloid suppressor cells and immune modulation in lung cancer.

Authors:  Minu K Srivastava; Åsa Andersson; Li Zhu; Marni Harris-White; Jay M Lee; Steven Dubinett; Sherven Sharma
Journal:  Immunotherapy       Date:  2012-03       Impact factor: 4.196

Review 5.  Myeloid-derived suppressor cells in transplantation and cancer.

Authors:  Jordi C Ochando; Shu Hsia Chen
Journal:  Immunol Res       Date:  2012-12       Impact factor: 2.829

6.  Contribution of MyD88 to the tumor exosome-mediated induction of myeloid derived suppressor cells.

Authors:  Yuelong Liu; Xiaoyu Xiang; Xiaoying Zhuang; Shuangyin Zhang; Cunren Liu; Ziqiang Cheng; Sue Michalek; William Grizzle; Huang-Ge Zhang
Journal:  Am J Pathol       Date:  2010-03-26       Impact factor: 4.307

7.  Induction of myeloid-derived suppressor cells by tumor exosomes.

Authors:  Xiaoyu Xiang; Anton Poliakov; Cunren Liu; Yuelong Liu; Zhong-bin Deng; Jianhua Wang; Ziqiang Cheng; Spandan V Shah; Gui-Jun Wang; Liming Zhang; William E Grizzle; Jim Mobley; Huang-Ge Zhang
Journal:  Int J Cancer       Date:  2009-06-01       Impact factor: 7.396

8.  IFNAR1 Controls Autocrine Type I IFN Regulation of PD-L1 Expression in Myeloid-Derived Suppressor Cells.

Authors:  Wei Xiao; John D Klement; Chunwan Lu; Mohammed L Ibrahim; Kebin Liu
Journal:  J Immunol       Date:  2018-05-11       Impact factor: 5.422

9.  The genotype of the transporter associated with antigen processing gene affects susceptibility to colorectal cancer in Japanese.

Authors:  Takenori Yamauchi; Shouhei Takeuchi; Naoki Maehara; Yoshiki Kuroda
Journal:  Environ Health Prev Med       Date:  2014-05-07       Impact factor: 3.674

10.  Targeting myeloid-derived suppressor cells using a novel adenosine monophosphate-activated protein kinase (AMPK) activator.

Authors:  Prashant Trikha; Robert L Plews; Andrew Stiff; Shalini Gautam; Vincent Hsu; David Abood; Robert Wesolowski; Ian Landi; Xiaokui Mo; John Phay; Ching-Shih Chen; John Byrd; Michael Caligiuri; Susheela Tridandapani; William Carson
Journal:  Oncoimmunology       Date:  2016-07-25       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.